Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.

It will be easier to spread out Part D drug costs over the year, while the total annual cost of medicines will be capped at ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The Centers for Medicare and Medicaid Services proposed changes to reduce prescription drug costs for Medicare Advantage and ...

Taxpayers spend 22% more per patient to support Medicare Advantage – the private alternative to Medicare that promised to ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

It's common for Medicare Advantage plans to require prior authorizations for tests or procedures that are out of the ordinary ...

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

Millions of Americans would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare ...

It's important not be to kept in the dark. If it weren't for Medicare, millions of older Americans today would struggle to ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

With fewer Part D plans and a $2,000 out-of-pocket cap, beneficiaries must rethink their Medicare drug coverage for 2025.